Led by principal investigator Stephanie DeLuca, Ph.D., the DeLuca Lab the impact of intensive neurorehabilitation treatments on children and adults with neuromotor impairments for more than 25 years. She has helped develop and rigorously test multiple neurorehabilitation therapy protocols and led numerous clinical research trials. Dr. DeLuca’s interdisciplinary research efforts have included; engagement of families, international training, and innovative teaching to prepare the next generation of clinicians and scientists.
- DeLuca has served as Co-Principal Investigator on two National Institutes of Health-funded multisite comparative effectiveness trials, and currently serves as a co-investigator and site-PI on the largest pediatric neurorehabilitation trial ever funded by the NIH in the United States.
- She is a member of the founding team of the first of its kind National Pediatric Rehabilitation Resource Center, an NIH-funded partnership between Virginia Tech, Ohio State University and Nationwide Children’s Hospital — to help clinical scientists in pediatric rehabilitation research by funding pilot studies and offering courses and mentored experiences.
- DeLuca plays a principal role in I-ACQUIRE, the nation's first multicenter pediatric stroke recovery trial, in which researchers and clinicians from 12 sites across the United States will evaluate an innovative therapeutic approach to help 8-month-old to 24-month-old infants. DeLuca co-developed the treatment approach used in the Phase III trial.